Wealth Enhancement Advisory Services’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Wealth Enhancement Advisory Services's PACB Position: Q3 2026 in Review
Wealth Enhancement Advisory Services reduced its Pacific Biosciences (PACB) stake by 74% in Q3 2026, selling an estimated $57.3K and leaving 14,422 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4080.
Wealth Enhancement Advisory Services first reported a position in PACB in Q3 2023 and has held it in 13 quarters since. The position peaked at $162K in Q4 2023. 205 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- Wealth Enhancement Advisory Services held 14,422 shares of Pacific Biosciences worth $33.2K as of Q3 2026.
- Wealth Enhancement Advisory Services sold 40,559 Pacific Biosciences shares in Q3 2026, an estimated $57.3K.
- Pacific Biosciences made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #4080 holding.
- Wealth Enhancement Advisory Services first reported a position in Pacific Biosciences in Q3 2023 and has held it in 13 quarters since.
- Wealth Enhancement Advisory Services's Pacific Biosciences position peaked at $162K in Q4 2023.
- 205 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.